Thus, these findings, for the first time, demonstrated that DEPTOR inhibits the tumorigenesis of ESCC cells and might serve as a potential therapeutic target or prognostic marker for human patients with ESCC. This evidence concerns the gene DEPTOR and esophageal squamous cell carcinoma.